GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly EBT Margin came in at 13.09% in Q2 2026, up 84.0% on a YoY basis from 7.11% in Q2 2025, and up 32.98% quarter-over-quarter from 9.84% in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) EBT Margin (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported EBT Margin for 5 consecutive years, with 13.09% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 84.0% year-over-year to 13.09%; the trailing twelve-month figure through Jun 2026 stood at 12.52% (down 149.0% YoY), and the FY2025 full-year result was 13.42%, up 30.0% from the prior year.
- EBT Margin grew to 13.09% in Q2 2026 per GEHC's latest filing, from 9.84% in the prior quarter.
- Across five years, EBT Margin topped out at 15.68% in Q4 2024 and bottomed at 9.84% in Q1 2026.
- Historically, EBT Margin has averaged 12.87% across 5 years, with a median of 12.8% in 2026.
- The sharpest annual moves came in 2024 and 2026: EBT Margin soared 398 bps in 2024, then slumped 464 bps in 2026.
- Over 5 years, EBT Margin stood at 14.54% in 2022, then slipped by 20 bps to 11.7% in 2023, then jumped by 34 bps to 15.68% in 2024, then declined by 8 bps to 14.41% in 2025, then retreated by 9 bps to 13.09% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 13.09%, 9.84%, and 14.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 13.09% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 24.17% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | -24.53% |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -5.37% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -39.59% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -68.58% |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 7.70% |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -19.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.09% |
| Mar 31, 2026 | 9.84% |
| Dec 31, 2025 | 14.41% |
| Sep 30, 2025 | 12.50% |
| Jun 30, 2025 | 12.24% |
| Mar 31, 2025 | 14.49% |
| Dec 31, 2024 | 15.68% |
| Sep 30, 2024 | 13.53% |
| Jun 30, 2024 | 11.94% |
| Mar 31, 2024 | 11.01% |
| Dec 31, 2023 | 11.70% |
| Sep 30, 2023 | 13.19% |
| Jun 30, 2023 | 11.83% |
| Mar 31, 2023 | 11.60% |
| Dec 31, 2022 | 14.54% |
| Sep 30, 2022 | 13.59% |
| Jun 30, 2022 | 14.25% |
| Mar 31, 2022 | 12.27% |